286 related articles for article (PubMed ID: 10606839)
1. Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide.
Abel S; Nichols DJ; Brearley CJ; Eve MD
Br J Clin Pharmacol; 2000 Jan; 49(1):64-71. PubMed ID: 10606839
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing.
Allen MJ; Nichols DJ; Oliver SD
Br J Clin Pharmacol; 2000 Sep; 50(3):247-53. PubMed ID: 10971309
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.
Le Coz F; Funck-Brentano C; Morell T; Ghadanfar MM; Jaillon P
Clin Pharmacol Ther; 1995 May; 57(5):533-42. PubMed ID: 7768076
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval.
Allen MJ; Oliver SD; Newgreen MW; Nichols DJ
Br J Clin Pharmacol; 2002 Jan; 53(1):59-65. PubMed ID: 11849196
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics and pharmacokinetics of the class III antiarrhythmic agent dofetilide (UK-68,798) in humans.
Tham TC; MacLennan BA; Burke MT; Harron DW
J Cardiovasc Pharmacol; 1993 Mar; 21(3):507-12. PubMed ID: 7681516
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
Jou MJ; Huang SC; Kiang FM; Lai MY; Chao PD
J Pharm Pharmacol; 1997 Nov; 49(11):1072-5. PubMed ID: 9401940
[TBL] [Abstract][Full Text] [Related]
7. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
Purkins L; Wood N; Kleinermans D; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):51-5. PubMed ID: 14616414
[TBL] [Abstract][Full Text] [Related]
8. The effects of cimetidine and ranitidine on the pharmacokinetics of cifenline.
Massarella JW; Defeo TM; Liguori J; Passe S; Aogaichi K
Br J Clin Pharmacol; 1991 Apr; 31(4):481-3. PubMed ID: 2049259
[TBL] [Abstract][Full Text] [Related]
9. Dynamic analysis of dofetilide-induced changes in ventricular repolarization.
Lande G; Maison-Blanche P; Fayn J; Ghadanfar M; Coumel P; Funck-Brentano C
Clin Pharmacol Ther; 1998 Sep; 64(3):312-21. PubMed ID: 9757155
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine.
Kamali F; Howes A; Thomas SH; Ford GA; Snoeck E
Br J Clin Pharmacol; 1997 Feb; 43(2):201-4. PubMed ID: 9131955
[TBL] [Abstract][Full Text] [Related]
11. The effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of metoprolol.
Chellingsworth MC; Laugher S; Akhlaghi S; Jack DB; Kendall MJ
Aliment Pharmacol Ther; 1988 Dec; 2(6):521-7. PubMed ID: 2979275
[TBL] [Abstract][Full Text] [Related]
12. The effect of histamine-2 receptor antagonists on tocainide pharmacokinetics.
North DS; Mattern AL; Kapil RP; Lalonde RL
J Clin Pharmacol; 1988 Jul; 28(7):640-3. PubMed ID: 2905709
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
14. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
McClellan KJ; Markham A
Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
[TBL] [Abstract][Full Text] [Related]
15. Effect of concomitantly administered cimetidine or ranitidine on the pharmacokinetics of the 5-HT2-receptor antagonist ritanserin.
Trenk D; Seiler KU; Buschmann M; Szathmary S; Benn HP; Jähnchen E
J Clin Pharmacol; 1993 Apr; 33(4):330-4. PubMed ID: 8473547
[TBL] [Abstract][Full Text] [Related]
16. Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.
Honig PK; Wortham DC; Zamani K; Conner DP; Mullin JC; Cantilena LR
Eur J Clin Pharmacol; 1993; 45(1):41-6. PubMed ID: 8405028
[TBL] [Abstract][Full Text] [Related]
17. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
[TBL] [Abstract][Full Text] [Related]
18. Dofetilide dose reductions and discontinuations in women compared with men.
Pokorney SD; Yen DC; Campbell KB; Allen LaPointe NM; Sheng S; Thomas L; Bahnson TD; Daubert JP; Picini JP; Jackson KP; Thomas KL; Al-Khatib SM
Heart Rhythm; 2018 Apr; 15(4):478-484. PubMed ID: 29605013
[TBL] [Abstract][Full Text] [Related]
19. Magnitude of increase in QTc interval after initiation of dofetilide in patients with persistent atrial fibrillation is associated with increased rates of pharmacological cardioversion and long-term freedom from recurrent atrial fibrillation.
Huang HD; Waks JW; Steinhaus DA; Zimetbaum P
Heart Rhythm; 2016 Jul; 13(7):1410-7. PubMed ID: 26921760
[TBL] [Abstract][Full Text] [Related]
20. Dofetilide, a novel class III antiarrhythmic agent.
Rasmussen HS; Allen MJ; Blackburn KJ; Butrous GS; Dalrymple HW
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S96-105. PubMed ID: 1279316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
